Internet Explorer 11 has been retired by Microsoft as of June 15, 2022. To get the best experience on this website, we recommend using a modern browser, such as Safari, Chrome or Edge.
A Scripps Clinic cardiologist today became the first in California to implant the world’s first smartphone-compatible cardiac monitor following FDA clearance.
Learn how the Watchman device, a treatment for AFib, helped a former Scripps patient reduce his risk for stroke without the need for blood thinning medications.
Philippe May forced to withdraw from a bicycle race because of a newly discovered heart condition, the world champion athlete returned to complete the race.
Scripps patients Joyce and John McNamara recently were both implanted with the same type of heart device at the same time to treat atrial fibrillation.
Scripps cardiologist Matthew Price, MD, explained stroke risk posed by AFib and discussed the latest techniques for detecting and treating the heart condition.
Media outlets covered the launch of a new Scripps Translational Science Institute study that uses wearable sensors to detect atrial fibrillation (AFib).
Researchers at the Scripps Translational Science Institute launched a home-based clinical trial using wearable sensor technology to identify people with AFib.